Monday, 11 September 2017

MTS Recommends... UHPLC, Part II: Benefits

UHPLC, Part II: Benefits
Aug 01, 2017
By Michael W. Dong, Davy Guillarme
Volume 35, Issue 8, pg 486–495

"This installment in our series on ultrahigh-pressure liquid chromatography (UHPLC) highlights its benefits in fast analysis, high-resolution separations, high performance liquid chromatography (HPLC) method development, reduced solvent and sample usage, and enhanced sensitivity and precision performance."

MTS Recommends... UHPLC, Part I: Perspectives and Instrumental Features

UHPLC, Part I: Perspectives and Instrumental Features
Jun 01, 2017

By Michael W. Dong
Volume 35, Issue 6, pg 374–381

"This installment highlights historical perspectives on the development of ultrahigh-pressure liquid chromatography (UHPLC) into a modern high performance liquid chromatography (HPLC) platform and describes the important instrumental features common to most commercial equipment."

MTS Recommends... How chemistry started life on Earth

Tuesday, 15 August 2017

MTS Recommends... Analytical Strategy in the Development of Biosimilars

Analytical Strategy in the Development of Biosimilars 

The author outlines an analytical strategy for establishing similarity in biosimilar development and approval.

M. DiPaola, “Analytical Strategy in the Development of Biosimilars," BioPharm International 30 (8) 2017.

Friday, 4 August 2017

Why are 'Bio' Test Methods So Tricky to Validate?

 

Thursday, 3 August 2017

MTS Recommends...

Responding To Regulatory Inspection Observations: Do's and Don'ts 


By Martin Lush, Global VP, NSF Health Sciences, in Outsourced Pharma
"It’s Friday, it’s late, and you are just leaving for the weekend. The inspection you hosted two weeks ago remains a painful memory. The exit meeting didn’t go well — five major observations, all relating to your quality system. When your boss enters your office, you know it’s not to wish you a good weekend. She looks stressed, anxious, and keen to off-load a big problem …"